National pholcodine consumption and prevalence of IgE-sensitization: A multicentre study

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 4, 2010, Pages 498-502

  Johansson, S G O ^a   Florvaag, E ^b,c   Oman H ^d   Poulsen, L K ^e   Mertes, P M ^f   Harper, N J N ^g   Garvey, L H ^e   Gerth Van Wijk, R ^h   Metso, T ⁱ   Irgens, A ^b   Dybendal, T ^j   Halsey, J ^k   Seneviratne, S L ^l   Guttormsen, A B ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d MIAB   (Sweden)

^e Rigshospitalet   (Denmark)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^j NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^k IBT Laboratories   (United States)

^l ST MARY S HOSPITAL   (United Kingdom)

more..

Author keywords

Anaphylaxis; Cough mixtures; IgE sensitization; International prevalence study; Pholcodine

Indexed keywords

4 AMINOPHENYLPHOSPHORYL CHOLINE; CHOLINE DERIVATIVE; DRUG ANTIBODY; IMMUNOGLOBULIN E; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; PHOLCODINE; SUXAMETHONIUM; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANTIBODY BLOOD LEVEL; ARTICLE; ATOPY; CONTROLLED STUDY; DATA BASE; DENMARK; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SENSITIZATION; DRUG USE; FINLAND; FRANCE; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NETHERLANDS; NORWAY; PRIORITY JOURNAL; SEROPREVALENCE; SWEDEN; UNITED KINGDOM; UNITED NATIONS; UNITED STATES;

ANAPHYLAXIS; ANTITUSSIVE AGENTS; CODEINE; CROSS REACTIONS; DRUG HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; MORPHINE; MORPHOLINES; NEUROMUSCULAR AGENTS; PHOSPHORYLCHOLINE; PREVALENCE; QUATERNARY AMMONIUM COMPOUNDS; SUCCINYLCHOLINE;

EID: 77649228666     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02193.x     Document Type: Article

References (10)

1. Baldo BA, Fisher MM. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983 306 : 262 264.
2. Mertes P-M, Aimone-Gastin I, Guéant-Rodriguez RM, Mouton-Faivre C, Audibert G, O'Brien J et al. Hypersensitivity reactions to neuromuscular blocking agents. Curr Pharm Des 2008 14 : 2809 2825.
3. Florvaag E, Johansson SGO, Öman H, Venemalm L, Degerbeck F, Dybendal T et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005 49 : 437 444.
4. Fisher MM, Baldo BA. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for detection of IgE antibodies in allergic subjects. Anaesthesiology Intens Care 2000 28 : 167 170.
5. Florvaag E, Johansson SGO, Öman H, Harboe T, Nopp A. Pholcodine stimulates a dramatic increase of IgE in IgE sensitized individuals. A pilot study. Allergy 2006 61 : 49 55.
6. Ringdén O, Persson U, Johansson SGO, Wilczek H, Gharton G, Groth CG et al. Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood 1983 61 : 1190 1195.
7. Harboe T, Johansson SGO, Florvaag E, Oman H. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 2007 62 : 1445 1450.
8. Florvaag E. Anaphylactic reactions during general anaesthesia. New Horiz 2005 2 : 1 6.
9. Florvaag E, Johansson SGO. The Pholcodine Story. North Am: Immunol Allergy Clin 2009 29 : 419 427.
10. Johansson SGO, Öman H, Nopp A, Florvaag E. Pholcodine caused anaphylaxis in Sweden 30-years ago. Allergy 2009 64 : 820 821.